No evidence for genetically determined alteration in insulin secretion or sensitivity predisposing the type 1 diabetes - A study of identical twins

被引:18
作者
Hawa, MI [1 ]
Castelli, MD [1 ]
Bonfanti, R [1 ]
Beyan, H [1 ]
Valeri, C [1 ]
Leslie, RDG [1 ]
机构
[1] St Bartholomews Hosp, InsT Cell & Mol Sci, Dept Diabet & Metab, London EC1A 7BE, England
关键词
D O I
10.2337/diacare.28.6.1415
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - To determine whether inherited changes in insulin secretion or sensitivity could predispose to type 1 diabetes, we studied identical twins of type 1 diabetic patients. RESEARCH DESIGN AND METHODS - We studied prospectively a consecutive series of 27 identical twins of patients with type 1 diabetes who were initially nondiabetic, as well as 14 control subjects, over a period of 18 years. Of these 27 twins, 15 remain nondiabetic (now estimated at low disease risk) and 12 developed diabetes (pre-diabetic twins). Subjects were tested when not diabetic on at least two occasions with an intravenous glucose tolerance test (IVGTT), and we estimated insulin secretion as first-phase insulin response (FPIR), glucose clearance (K-g), and insulin sensitivity both by homeostasis model assessment of insulin resistance (HOMA-IR) and relative to insulin response by the basal HOMA-IR-to-FPIR ratio. RESULTS- Twins now at low risk and control subjects had similar fasting blood glucose and insulin levels, FPIR, K-g, HOMA-IR, and HOMA-IR-to-FPIR ratio. In contrast, pre-diabetic twins compared with control twins had higher fasting insulin levels (10.3 +/- 6.0 vs. 4.6 +/- 4.0 mIU/ml), lower FPIR (245 +/- 129 vs. 796 +/- 622 mIU . ml(-1) . 10 min(-1)), lower K-g (1.5 +/- 0.6 vs. 2.6 +/- 0.8% per min), and higher HOMA-IR-to-FPIR ratio (0.007 +/- 0.005 vs. 0.001 +/- 0.0009) (all P < 0.01). CONCLUSIONS- These observations in low-risk nondiabetic identical twins failed to identify a familial alteration in either insulin secretion or sensitivity predisposing to type 1 diabetes.
引用
收藏
页码:1415 / 1418
页数:4
相关论文
共 21 条
[1]   Type 1 diabetes: new perspectives on disease pathogenesis and treatment [J].
Atkinson, MA ;
Eisenbarth, GS .
LANCET, 2001, 358 (9277) :221-229
[2]   SUSCEPTIBILITY TO HUMAN TYPE-1 DIABETES AT IDDM2 IS DETERMINED BY TANDEM REPEAT VARIATION AT THE INSULIN GENE MINISATELLITE LOCUS [J].
BENNETT, ST ;
LUCASSEN, AM ;
GOUGH, SCL ;
POWELL, EE ;
UNDLIEN, DE ;
PRITCHARD, LE ;
MERRIMAN, ME ;
KAWAGUCHI, Y ;
DRONSFIELD, MJ ;
POCIOT, F ;
NERUP, J ;
BOUZEKRI, N ;
CAMBONTHOMSEN, A ;
RONNINGEN, KS ;
BARNETT, AH ;
BAIN, SC ;
TODD, JA .
NATURE GENETICS, 1995, 9 (03) :284-292
[3]   Association between infant growth before onset of juvenile type-1 diabetes and autoantibodies to IA-2 [J].
Bruining, GJ .
LANCET, 2000, 356 (9230) :655-656
[4]  
FOULIS AK, 1984, DIABETOLOGIA, V26, P456
[5]   Insulin resistance is a risk factor for progression to Type 1 diabetes [J].
Fourlanos, S ;
Narendran, P ;
Byrnes, GB ;
Colman, PG ;
Harrison, LC .
DIABETOLOGIA, 2004, 47 (10) :1661-1667
[6]  
Gavin JR, 1999, DIABETES CARE, V22, pS5
[7]  
Gavin JR, 1997, DIABETES CARE, V20, P1183
[8]   Type 1 diabetes manifested solely by 2-h oral glucose tolerance test criteria [J].
Greenbaum, CJ ;
Cuthbertson, D ;
Krischer, JP .
DIABETES, 2001, 50 (02) :470-476
[9]  
HARRIS M, 1979, DIABETES, V28, P1039
[10]   Value of antibodies to islet protein tyrosine phosphatase-like molecule in predicting type 1 diabetes [J].
Hawa, M ;
Rowe, R ;
Lan, MS ;
Notkins, AL ;
Pozzilli, P ;
Christie, MR ;
Leslie, RDG .
DIABETES, 1997, 46 (08) :1270-1275